Anadolu Medical Center
The cost of melanoma treatment in Turkey can vary depending on the treatment plan selected. A consultation with a radiation oncologist costs $200, and 5 fractions of stereotactic radiosurgery (SRS) are priced at $6,500. An MRI of the brain with contrast is $750. A PET-CT scan is $700, and a BRAF mutation test is approximately $1,800. Immunotherapy treatment, consisting of three courses, starts at $5,600 for the first course and $5,500 for each subsequent one. The treatment plan is personalized based on the patient"s needs and the doctor"s assessment.
| Turkey | Austria | Spain | |
| Mohs microsurgery | from $2,200 | from $4,000 | from $2,200 |
| Melanoma surgery | from $3,500 | from $9,500 | from $4,500 |
| Actinium-225 Therapy | from $22,955 | from $55,000 | from $45,000 |
| Immunotherapy with Keytruda (Pembolizumab) | from $3,300 | from $15,000 | from $15,000 |
| Wide excision of melanoma | from $4,000 | - | from $6,348 |
900+ melanoma procedures performed – Dr. Bülent Karagöz specializes in immunotherapy and targeted therapies at Anadolu Medical Center.
Prof. Dr. Eda Tanrikulu specializes in metastatic malignant melanoma and has a leadership role in cancer case evaluations at Anadolu Medical Center.
Mustafa Solak has performed 1,100+ cancer treatments, including melanoma, at Hisar Hospital Intercontinental.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Written by Veronika Kazina